In this episode, we explore the strategic use of natural medications in psychiatry, focusing on combination therapies for various mental health conditions. Dr. David Mischoulon discusses potential synergies between natural remedies and conventional drugs, as well as all-natural combinations. But how do we balance efficacy with safety when using these less-studied treatments?

Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies
• Potential Combinations of Natural Medication for Psychiatric Disorders

In this episode, we explore the use of memantine in treating trichotillomania and skin picking disorder. Could this common Alzheimer's medication be the breakthrough we've been waiting for in managing body-focused repetitive behaviors? Dr. Bob Hudak discusses a promising study that offers new hope for patients struggling with these often-overlooked conditions.

Faculty: Robert Hudak, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 60
• Efficacy of Memantine in Treating Trichotillomania and Skin-Picking Disorder

In this episode, we explore Ashwagandha, a versatile natural remedy in psychiatry. We discuss its potential applications in treating anxiety, depression, OCD, and other mental health disorders. Could this ancient herb be the key to managing treatment-resistant patients?

Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies
• Ashwagandha (ASW): Potential Indications and Administration in Psychiatric Disorders

In this episode, we explore the controversial use of electroconvulsive therapy (ECT) in adolescents with severe depression and suicidality. We discuss a study examining ECT's effectiveness, factors influencing outcomes, and its potential as a treatment option. Is ECT a viable last resort for treatment-resistant depression in teens?

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 19
• Electroconvulsive Therapy for Adolescents With Severe Depression and Suicidality

In this episode, we explore the potential uses of Cannabidiol (CBD) in psychiatric practice. We discuss its mechanisms, evidence for various disorders, and guidelines for safe use. Is CBD the next breakthrough in mental health treatment, or just another passing trend?

Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies
• Cannabidiol: Evidence for Psychiatric Disorders and Recommendations for Using It

In this episode, we explore the use of medical cannabis in treating Parkinson's disease. We discuss a retrospective study that reveals promising results for both motor and non-motor symptoms. Could medical cannabis be the versatile solution we've been seeking for Parkinson's treatment?

Faculty: Gregory Pontone, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 59
• Medical Cannabis in the Treatment of Parkinson’s Disease

In this episode, we explore the potential of N-acetylcysteine (NAC) in treating mood disorders. We discuss its mechanism of action, clinical evidence for its use in depression and bipolar disorder, and its possible benefits for both adults and children. Could this natural compound revolutionize our approach to mood stabilization?

Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies
• Exploring the Evidence of N-Acetyl-Cysteine (NAC) for Mood Disorders

In this episode, we explore the potential use of probiotics in treating ADHD symptoms in children and adolescents. Could the gut microbiome hold the key to managing this complex neurodevelopmental disorder? We discuss a recent meta-analysis and its implications for future research and clinical practice.

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 19
• Efficacy of Probiotics in Treating ADHD Symptoms

In this episode, we explore the challenges and best practices for managing bipolar disorder during pregnancy. We discuss key medications, their risks and benefits, and the importance of individualized treatment plans. How do we balance maternal mental health with fetal safety when treating bipolar disorder in pregnant women?

Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1 CME: Perinatal Treatment of Bipolar Disorder
• Guiding Principles for Treating Bipolar Disorder During Pregnancy

In this episode, we explore a recent study challenging the safety concerns surrounding haloperidol use in older patients post-surgery. We discuss its implications for managing delirium and compare it to other antipsychotics. Could haloperidol be the unsung hero in our psychopharmacological arsenal?

Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 59
• Comparative Safety of Oral Antipsychotics for Adverse Events in Adults After Surgery

In this episode, we explore the use of atypical antipsychotics during pregnancy for women with bipolar disorder. We discuss recent research findings, potential risks, and the delicate balance between managing maternal mental health and fetal safety. How do clinicians approach this challenging clinical decision?

Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1 CME: Perinatal Treatment of Bipolar Disorder
• Risks of Using Antipsychotics During Pregnancy